This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Undervalued Stocks for 2012

NEW YORK ( TheStreet) -- The goal of a value investor is to identify stocks trading below their calculated intrinsic fair value and purchasing them with an adequate margin of safety. Astute investors can examine these five stocks and use the information as a basis for due diligence. These stocks have their P/E ratios in the range of 5 to 12 apart from Calgon which is flirting with its yearly lows.

A consensus forecast of analysts polled by Bloomberg sees upside opportunity of 31% to 58% for these five stocks, with buy and hold guidance of 75% and 20% on average, respectively.

The five selected stocks are listed in ascending order of upside potential.


5. Agilent Technologies (A - Get Report) is a premier measurement company and technology leader in chemical analysis, life sciences, electronics and communications serving customers in more than 100 countries.

For fiscal 2011, Agilent reported net revenue of $6.6 billion, up 22% compared to the prior fiscal. Net income rose 47.9% to $1,012 million, while total orders amounted to $6,769 million, an increase of 18% from the earlier year.

The company estimates revenue of $1.65 billion to $1.67 billion for the 2012 first quarter with non-GAAP earnings of 67 cents to 69 cents per share (EPS). For fiscal 2012, revenue guidance is between $6.85 billion to $7.15 billion and earnings per share (EPS) in the range of $3 to $3.35.

Last month, Agilent completed the acquisition of BioSystem Development -- a privately held company engaged in the development and manufacture of the AssayMAP Microchromatography platform -- and signed a definitive acquisition agreement with Accelicon Technologies.

Of the 17 analysts covering the stock, 94% recommend a buy and rest suggest a hold. The stock's average 12-month price target is $47.6, or 31.5% above the current price, according to a Bloomberg consensus.

Agilent is currently trading at a P/E ratio of 11.8.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
A $42.50 0.00%
CCC $21.15 0.00%
CLF $5.17 0.00%
DAN $22.13 0.00%
MWW $6.09 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs